These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 905317)

  • 1. Diet-induced hyperuricaemia and platelet aggregation in rats.
    Winocour PD; Munday KA; Taylor TG; Turner MR
    Proc Nutr Soc; 1977 Sep; 36(2):86A. PubMed ID: 905317
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet aggregation in rats made hyperuricaemic with nucleic adid-rich diets containing oxonate, and inhibitor of uricase [proceedings].
    Winocour PD; Munday KA; Taylor TG; Tuner MR
    Proc Nutr Soc; 1976 Sep; 35(2):54A-55A. PubMed ID: 972878
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet aggregation in rats in relation to hyperuricaemia induced by dietary single-cell protein and to protein deficiency.
    Winocour PD; Turner MR; Taylor TG; Munday KA
    Thromb Haemost; 1978 Apr; 39(2):346-59. PubMed ID: 580986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diurnal variation in serum uric acid of rats fed potassium oxonate.
    Newburger J; Combs AB; Hsu TF
    Drug Chem Toxicol; 1978; 1(3):231-5. PubMed ID: 573681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allantoxanamide: a potent new uricase inhibitor in vivo.
    Johnson WJ; Chartrand A
    Life Sci; 1978 Nov; 23(22):2239-44. PubMed ID: 723476
    [No Abstract]   [Full Text] [Related]  

  • 6. Adjuvant polyarthritis. VI. Effect of oxonate-induced hyperuricemia on the development of acute inflammation, immune response and adjuvant arthritis.
    Chang YH; Bluestone R
    J Pharmacol Exp Ther; 1981 Dec; 219(3):731-4. PubMed ID: 6975369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High steady-state levels of uric acid produced in rats by dietary training and potassium oxonate.
    Newburger J; Hsu TF; Combs AB
    J Pharm Sci; 1979 May; 68(5):651-2. PubMed ID: 430510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological characteristics of various experimental models for the study of disorders in purine metabolism.
    Musil J
    Adv Exp Med Biol; 1977; 76B():179-88. PubMed ID: 16457
    [No Abstract]   [Full Text] [Related]  

  • 9. Some in vivo effects in the rat induced by chlorprothixene and potassium oxonate.
    Stavric B; Clayman S; Gadd RE; Hébert D
    Pharmacol Res Commun; 1975 Apr; 7(2):117-24. PubMed ID: 1144488
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of fructose administration on serum urate levels in the uricase inhibited rat.
    Stavric B; Johnson WJ; Clayman S; Gadd RE; Chartrand A
    Experientia; 1976 Mar; 32(3):373-4. PubMed ID: 1253916
    [No Abstract]   [Full Text] [Related]  

  • 11. Oxonate-induced hyperuricemia and orotic aciduria in mice.
    Mangoff SC; Milner JA
    Proc Soc Exp Biol Med; 1978 Jan; 157(1):110-5. PubMed ID: 622363
    [No Abstract]   [Full Text] [Related]  

  • 12. Uricostatic effect of allopurinol in the allantoxanamide-treated rat: a new method for evaluating antiuricopathic drugs.
    Hropot M; Muschaweck R; Klaus E
    Adv Exp Med Biol; 1984; 165 Pt A():175-8. PubMed ID: 6720375
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperuricemia and locomotor activity in developing rats.
    Barrera CM; Hunter RE; Dunlap WP
    Pharmacol Biochem Behav; 1989 Jun; 33(2):367-9. PubMed ID: 2813475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allantoxanamide-induced myocardial necrosis in Sprague-Dawley vs spontaneously hypertensive rats.
    Wexler BC
    Proc Soc Exp Biol Med; 1982 Sep; 170(4):476-85. PubMed ID: 7122477
    [No Abstract]   [Full Text] [Related]  

  • 15. Uric acid kidney stones induced in rats by oxonic acid, a uricase inhibitor.
    Stavric B; Nera EA; Johnson WJ; Salem FA
    Invest Urol; 1973 Jul; 11(1):3-8. PubMed ID: 4724271
    [No Abstract]   [Full Text] [Related]  

  • 16. [Inhibition of adjuvant arthritis by oxonate: influence of uricemia (author's transl)].
    Lussier A; de Médicis R; Mathon G
    Experientia; 1978 Aug; 34(8):995-6. PubMed ID: 700052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxonic acid-induced hyperuricemia elevates plasma aldosterone in experimental renal insufficiency.
    Eräranta A; Kurra V; Tahvanainen AM; Vehmas TI; Kööbi P; Lakkisto P; Tikkanen I; Niemelä OJ; Mustonen JT; Pörsti IH
    J Hypertens; 2008 Aug; 26(8):1661-8. PubMed ID: 18622246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological effects of 1,3,5-triazines and their excretion characteristics in the rat.
    Hropot M; Sörgel F; von Kerékjártó B; Lang HJ; Muschaweck R
    Adv Exp Med Biol; 1980; 122A():269-76. PubMed ID: 6893515
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experimental nephropathy caused by hyperuricemia in rats. Preliminary observations].
    Chériè Lignière G; Carrabba M; Multeni M; Colombo B
    Reumatismo; 1977; 29(2-3):120-4. PubMed ID: 616958
    [No Abstract]   [Full Text] [Related]  

  • 20. A preliminary report of nephropathy in hyperuricemic rats.
    Waisman J; Bluestone R; Klinenberg JR
    Lab Invest; 1974 Jun; 30(6):716-22. PubMed ID: 4835598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.